Pharmacotherapy for Focal Seizures in Children and Adolescents

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Drugs

• Publication date

  2018-08-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40265-018-0959-6PMID 30128698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A review of the pharmacology and clinical efficacy of brivaracetam

  2018cited by this paper
• Treatment of medically refractory seizures with responsive neurostimulation: 2 pediatric cases.

  2018cited by this paper
• Carbamazepine, oxcarbazepine, and eslicarbazepine

  2018cited by this paper
• Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta‐analysis

  2018cited by this paper
• Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.

  2018cited by this paper
• Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings

  2018cited by this paper
• Safety of antiepileptic drugs in children and young people: A prospective cohort study.

  2018cited by this paper
• Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.

  2018cited by this paper
• Meta-analyses of newer antiepileptic drugs as adjunct for treatment of focal epilepsy in children.

  2018cited by this paper
• 63 – Neurophysiology of Seizures and Epilepsy

  2017cited by this paper
• Brivaracetam: a novel antiepileptic drug for focal-onset seizures

  2017cited by this paper
• Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures

  2017cited by this paper
• ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

  2017cited by this paper
• New developments in the management of partial-onset epilepsy: role of brivaracetam

  2017cited by this paper
• Neurostimulation Techniques for the Treatment of Epilepsy

  2017cited by this paper
• Ezogabine skin discoloration is reversible after discontinuation

  2017cited by this paper
• Current role of perampanel in pediatric epilepsy

  2017cited by this paper
• Extrapolating evidence of antiepileptic drug efficacy in adults to children ≥2 years of age with focal seizures: The case for disease similarity

  2017cited by this paper
• The New Classification of Seizures by the International League Against Epilepsy 2017

  2017cited by this paper
• Felbamate as an add-on therapy for refractory partial epilepsy.

  2017cited by this paper
• Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trials

  2017cited by this paper
• Antiepileptic drugs for chronic non-cancer pain in children and adolescents.

  2017cited by this paper
• Epilepsy surgery in children

  2017cited by this paper
• Emerging Antiepileptic Drugs for Severe Pediatric Epilepsies.

  2016cited by this paper
• The role of vagus nerve stimulation in refractory epilepsy

  2016cited by this paper
• Exploring human epileptic activity at the single-neuron level.

  2016cited by this paper
• Toward a Mechanistic Understanding of Epileptic Networks

  2016cited by this paper
• Brain MRI findings with vigabatrin therapy: case report and literature review.

  2016cited by this paper
• Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives

  2016cited by this paper
• Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta‐analyses

  2016cited by this paper
• The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist

  2015cited by this paper
• Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action

  2015cited by this paper
• Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects

  2015cited by this paper
• The ketogenic diet in pharmacoresistant childhood epilepsy

  2015cited by this paper
• Clinical Pharmacokinetic and Pharmacodynamic Profile of Lacosamide

  2015cited by this paper
• Gabapentin and pregabalin

  2015cited by this paper
• Phenytoin and fosphenytoin

  2015cited by this paper
• Mechanisms of Levetiracetam in the Control of Status Epilepticus and Epilepsy

  2014cited by this paper
• Update on once-daily zonisamide monotherapy in partial seizures

  2014cited by this paper
• Adjunctive zonisamide therapy in the long‐term treatment of children with partial epilepsy: Results of an open‐label extension study of a phase III, randomized, double‐blind, placebo‐controlled trial

  2014cited by this paper
• Experience in the use of clobazam in the treatment of Lennox–Gastaut syndrome

  2014cited by this paper
• Recognizing Seizures and Epilepsy: Insights from Pathophysiology

  2014cited by this paper
• Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders.

  2014cited by this paper
• Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines.

  2014cited by this paper
• The clinical pharmacology of traditional antiepileptic drugs.

  2014cited by this paper
• Advances in epilepsy treatment: lacosamide pharmacokinetic profile

  2014cited by this paper
• Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.

  2014cited by this paper
• Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.

  2014cited by this paper
• Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

  2014cited by this paper
• A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012

  2013cited by this paper
• Gabapentin add-on for drug-resistant partial epilepsy.

  2013cited by this paper
• Enzyme induction with antiepileptic drugs: Cause for concern?

  2013cited by this paper
• Pharmacotherapy of Focal Epilepsy in Children: A Systematic Review of Approved Agents

  2013cited by this paper
• Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures

  2013cited by this paper
• Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures.

  2013cited by this paper
• Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy

  2013cited by this paper
• Vigabatrin for refractory partial epilepsy.

  2013cited by this paper
• Management of Focal-Onset Seizures

  2012cited by this paper
• Vigabatrin for childhood partial-onset epilepsies.

  2012cited by this paper
• Antiepileptic drugs in women with epilepsy during pregnancy

  2012cited by this paper
• Lacosamide

  2012cited by this paper
• Vigabatrin-associated Visual Field Loss

  2012cited by this paper
• Efficacy of antiepileptic drugs in adults predicts efficacy in children

  2012cited by this paper
• Current position of phenobarbital in epilepsy and its future

  2012cited by this paper
• GABAA Receptor Physiology and Its Relationship to the Mechanism of Action of the 1,5-Benzodiazepine Clobazam

  2012cited by this paper
• Pharmacotherapy of Epilepsy

  2011cited by this paper
• Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.

  2011cited by this paper
• Lacosamide

  2011cited by this paper
• Revisiting AMPA Receptors as an Antiepileptic Drug Target

  2011cited by this paper
• Rufinamide for Pediatric Patients with Lennox-Gastaut Syndrome

  2011cited by this paper
• Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs

  2011cited by this paper
• Single-neuron dynamics in human focal epilepsy

  2011cited by this paper
• Neurostimulation: vagus nerve stimulation and beyond.

  2011cited by this paper
• A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin

  2010cited by this paper
• Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.

  2010cited by this paper
• Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009

  2010cited by this paper
• Rufinamide: A Novel Broad-Spectrum Antiepileptic Drug

  2010cited by this paper
• Choreoathetosis during phenytoin treatment.

  2009cited by this paper
• The Investigational Anticonvulsant Lacosamide Selectively Enhances Slow Inactivation of Voltage-Gated Sodium Channels

  2008cited by this paper
• Pharmacokinetics, Efficacy, and Tolerability of Eslicarbazepine Acetate in Children and Adolescents With Epilepsy

  2008cited by this paper
• Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results.

  2008cited by this paper
• Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

  2008cited by this paper
• Inhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patients

  2007cited by this paper
• The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

  2007cited by this paper
• Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.

  2007cited by this paper
• Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy

  2007cited by this paper
• Weight issues for people with epilepsy—A review

  2007cited by this paper
• Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy.

  2006cited by this paper
• Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas.

  2006cited by this paper
• Management of focal-onset seizures: an update on drug treatment.

  2006cited by this paper
• The mechanisms of action of gabapentin and pregabalin.

  2006cited by this paper
• Treatment of partial seizures with gabapentin: Double‐blind, placebo‐controlled, parallel‐group study *

  2006cited by this paper
• Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures

  2006cited by this paper
• Effects of the Novel Antiepileptic Drug Lacosamide on the Development of Amygdala Kindling in Rats

  2006cited by this paper
• Lamotrigine versus carbamazepine monotherapy for epilepsy.

  2006cited by this paper
• Hyponatremia from oxcarbazepine and carbamazepine

  2005cited by this paper
• Oxcarbazepine adjunctive therapy in infants and young children with partial seizures

  2005cited by this paper
• Pregabalin

  2005cited by this paper
• Effect of Antiepileptic Drugs on Reproductive Endocrine Function in Individuals with Epilepsy

  2005cited by this paper
• Randomized dose‐controlled study of topiramate as first‐line therapy in epilepsy

  2005cited by this paper

• Electroencephalography, Magnetic Resonance Imaging and Response to Treatment in Children with Focal Seizures A Prospective Cohort Study

  2023cites this paper
• Discovery of Novel Isonipecotic Acid-Based Heteroaryl Amino Acid Derivatives as Potential Anticonvulsant Agents: Design, Synthesis, In-Silico ADME Study, and Molecular Docking Studies

  2023cites this paper
• Zonisamide

  2023cites this paper
• Treatment of Focal-Onset Seizures in Children: Should This Be More Etiology-Driven?

  2022cites this paper
• Social cognition in children and adolescents with epilepsy: A meta-analysis

  2022cites this paper
• Synthesis, Anticonvulsant, and Antinociceptive Activity of New 3-(2-Chlorophenyl)- and 3-(3-Chlorophenyl)-2,5-dioxo-pyrrolidin-1-yl-acetamides

  2021cites this paper
• Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry

  2021cites this paper
• Is the prevalence of thyroid disease higher in children receiving antiepileptic medication? A systematic review and meta-analysis.

  2021cites this paper
• A Comprehensive, Updated Review for the Clinician

  year unknowncites this paper